Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2010
03/09/2010US7674958 GRG23 and GRG51 genes conferring herbicide resistance
03/09/2010US7674957 Stress responsive transcription factor involved in plant growth and development and methods thereof
03/09/2010US7674956 Hydrolases; insect/disease resistant plants; controlling cellulose concentration during cell wall deposition
03/09/2010US7674955 transgenic plant stably transformed with a gene encoding a Hd-Zip domain; drought resistant;
03/09/2010US7674954 Using a transcription factor that comprises a homeodomain associated with a leucine zipper; sunflower; oxidative stress
03/09/2010US7674953 Method for producing transgenic plants with increased yield, comprising expressing of haemoglobin from Arabidopsis
03/09/2010US7674952 Stress-inducible plant promoters
03/09/2010US7674951 Isolated cellulose synthase promoter regions
03/09/2010US7674950 Plant regulatory sequences for selective control of gene expression
03/09/2010US7674896 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
03/09/2010US7674895 Compositions and methods for siRNA inhibition of angiogenesis
03/09/2010US7674894 Nucleic acid molecule having promoter activity; expressing herbicide tolerance gene in plants
03/09/2010US7674893 Promoters for regulation of gene expression in plant roots
03/09/2010US7674892 Hsp70 from Arthrobacter
03/09/2010US7674891 encoding CD36, Gqi9, and G protein-coupled receptor 84 (GPR84) proteins; permits the screening for modulators of taste activity
03/09/2010US7674890 stimulating gastrointestinal epithelial cell proliferation, patient suffering from degeneration, mucositis, inflammatory bowel disease, or undergoing cancer treatment, or restore the digestive and absorptive processes following surgical resection of the intestine; bioassay; polynucleotide gene therapy
03/09/2010US7674889 makes it possible to detect the expression of the same in various tissues, analyze their structures and functions, and produce the human proteins encoded by the genes by genetic engineering; hereditary diseases and cancer
03/09/2010US7674888 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
03/09/2010US7674779 chemically modified oligonucleotides; double stranded iRNA agent; comprising a cholesterol moiety; increased stability in a biological sample
03/09/2010US7674778 Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine
03/09/2010US7674777 Immunostimulatory nucleic acid molecules
03/09/2010US7674752 Functional protein arrays
03/09/2010US7674621 Lambda phages useful in introducing recombineering functions into host cells; origin of replication (ori) selected from pSC101, colE1, pBBR1 and RK2
03/09/2010US7674618 Expression vector
03/09/2010US7674617 MiRNA molecules isolated from human embryonic stem cell
03/09/2010US7674612 Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof
03/09/2010US7674611 An isolated protein comprising the amino acid sequence of SEQ ID NO: 1, and having an ethylenediamine-N,N'-disuccinate:ethylenediaminelyase activity and having improved heat resistance
03/09/2010US7674607 DNA encoding G+C-rich promoter binding protein
03/09/2010US7674606 Protein isolation
03/09/2010US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution
03/09/2010US7674591 Methods of using antibodies to human IL-13bc for inhibiting IL-13 binding
03/09/2010US7674586 Methods of identifying modulators of L-glutamate-gated chloride channel proteins from Rhipicephalus sanguineus
03/09/2010US7674585 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
03/09/2010US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
03/09/2010US7674468 Herpes simplex virus (HSV) comprising deletion, insertion, or substitution in each gamma 34.5 gene; lysis
03/09/2010US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist
03/09/2010US7674462 Transforming growth factor receptor specific immunoglobulin for use in diagnosis prvention and treatment of tumor disorders; immunotherapy
03/09/2010US7674455 treating a mammal having amyotrophic lateral sclerosis by transducing a motor neuron of the mammal with an insulin-like growth factor I (IGF-1) gene or a glial cell line-derived neurotrophic factor (GDNF) gene; neurodegenerative disorders
03/09/2010US7674454 Enzyme-prodrug therapy for prosthetic joint repair
03/09/2010US7674447 carbon nanotubes as electrodes; for biopolymers such as DNA and RNA
03/09/2010US7674291 Generating transgenic cell which express keratinocyte growth factor-2 (KGF-2) for use ase tool in treatment of ulcers and inflammatory bowel disease
03/09/2010CA2493509C Rationally designed polysaccharide lyases derived from chondroitinase b
03/09/2010CA2420495C A novel cationic lipopolymer as biocompatible gene delivery agent
03/09/2010CA2419453C Mutant transglutaminase from streptoverticillium having modified substrate specificity
03/09/2010CA2402955C Nanoparticles having oligonucleotides attached thereto and uses therefor
03/09/2010CA2386180C Vectors and methods for recombinant protein expression
03/09/2010CA2382464C High-affinity choline transporter
03/09/2010CA2368994C Preparation of biologically active molecules
03/09/2010CA2342960C G protein-coupled receptor antagonists
03/09/2010CA2331726C Modulation of molecular interaction sites on rna and other biomolecules
03/09/2010CA2302881C Method for quantification of an analyte
03/09/2010CA2293810C Fatty acid desaturases and mutant sequences thereof
03/09/2010CA2264963C Protein markers for esophageal cancer
03/09/2010CA2173730C Transgenic plants that exhibit enhanced nitrogen assimilation
03/09/2010CA2172153C Regulation of bcl-2 gene expression
03/09/2010CA2159702C High molecular and low molecular fractions of von willebrand factor
03/09/2010CA1341601C Anti-sense regulation of gene expression in plant cells
03/05/2010CA2679676A1 Monoclonal antibodies for neutralizing anthrax toxin
03/04/2010WO2010025465A1 Plant glutamine phenylpyruvate transaminase gene and transgenic plants carrying same
03/04/2010WO2010025420A2 Methods of identifying functional characteristics of promoters, transcription modifying proteins and transcription modulating agents
03/04/2010WO2010025395A2 Hydrolases, nucleic acids encoding them and methods for making and using them
03/04/2010WO2010025374A2 Manipulation of snf1 protein kinase activity for altered oil content in oleaginous organisms
03/04/2010WO2010025320A1 Novel hemipteran and coleopteran active toxin proteins from bacillus thuringiensis
03/04/2010WO2010025310A2 Methods and devices for high fidelity polynucleotide synthesis
03/04/2010WO2010025287A2 Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
03/04/2010WO2010025285A1 A dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants
03/04/2010WO2010025247A1 Epicatechin glucosyltransferase
03/04/2010WO2010025238A2 Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
03/04/2010WO2010025213A1 Methods for increasing grain value and compositions thereof
03/04/2010WO2010025085A2 Ketoreductase polypeptides for the stereoselective production of (4s)-3[(5s)-5(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one
03/04/2010WO2010025077A2 Genomic dna labeling and amplification
03/04/2010WO2010025016A2 Enhancement of transgene expression from virus-based vaccine vectors using suppressors of the type 1 interferon response
03/04/2010WO2010024976A1 Soybean plant and seed corresponding to transgenic event mon87754 and methods for detection thereof
03/04/2010WO2010024905A1 Genetically stabilized tandem gene duplication
03/04/2010WO2010024699A1 Methods and compositions for increasing storage-life of fruit
03/04/2010WO2010024493A1 Preparation of the streptomyces strains producing alpha-glucosidase inhibitors transformed by the recombinant vectors harboring the salbostatin biosynthesis gene cluster, and mass-production method of these inhibitors
03/04/2010WO2010024483A1 Recombinant adenovirus comprising tissue-specific promoter and tumor-targeting trans-splicing ribozyme and uses thereof
03/04/2010WO2010024445A1 Process for production of optically active amine derivative
03/04/2010WO2010024444A1 Process for production of optically active amine derivative
03/04/2010WO2010024440A1 Active-oxygen-resistant bacterium, and method for utilizing same
03/04/2010WO2010024437A1 Triterpene oxidase derived from glychyrrhiza plant, gene encoding the oxidase, and method for utilizing the gene
03/04/2010WO2010024405A1 Ifn type-1 production inhibitor and method for searching for same
03/04/2010WO2010024374A1 Method for detecting the drug effects of dna methylation-inhibitors
03/04/2010WO2010024367A1 Novel parachlorella micro-alga
03/04/2010WO2010024289A1 Marker for detecting il-17-producing helper t cell, and method for detecting il-17-producing helter t cell
03/04/2010WO2010024269A1 Dwarf transgenic plant, and gene for induction of dwarfing
03/04/2010WO2010024267A1 Process for producing useful substance
03/04/2010WO2010024262A1 Transfection agent
03/04/2010WO2010024251A1 Method for preparing fecal sample, fecal sample preparation solution, and feces collection kit
03/04/2010WO2010024231A1 METHOD FOR PRODUCTION OF cDNA LIBRARY HAVING REDUCED CONTENT OF cDNA CLONE DERIVED FROM HIGHLY EXPRESSED GENE
03/04/2010WO2010024118A1 Novel recombinant protein having caspase recruitment domain applied thereto, and use thereof
03/04/2010WO2010024091A1 Evaluation/screening method for diseases associated with d-amino acid utilizing dao1-/- mouse
03/04/2010WO2010023974A1 Rice gene capable of imparting wide-spectrum disease resistance
03/04/2010WO2010023928A1 Transgenic bird and method for production thereof, and method for production of protein
03/04/2010WO2010023917A1 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
03/04/2010WO2010023910A1 Method for modifying sugar chain structure in plant, and plant produced by the method
03/04/2010WO2010023877A1 Prmt1 for target genes of cancer therapy and diagnosis
03/04/2010WO2010023866A1 Syngr4 for target genes of cancer therapy and diagnosis
03/04/2010WO2010023864A1 Oip5 as a target gene for cancer therapy and diagnosis
03/04/2010WO2010023856A1 Pancreatic cancer related gene ttll4